Cost and Cost-Effectiveness of Treating Human Epidermal Growth Factor Receptor 2-Low Metastatic Breast Cancer.

Journal:
Journal of Clinical Oncology
Published:
Affiliations:
5
Authors:
9
Institutions Authors Share
Stanford University, United States of America (USA)
6.500000
0.72
Stanford University School of Medicine, United States of America (USA)
2.500000
0.28